BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 84 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $307,000 | +9.3% | 26,000 | +22.2% | 0.01% | 0.0% |
| Q2 2022 | $281,000 | +16.1% | 21,277 | +167.1% | 0.01% | -29.4% |
| Q3 2021 | $242,000 | -0.8% | 7,967 | -5.1% | 0.02% | -29.2% |
| Q2 2021 | $244,000 | -50.0% | 8,393 | -25.7% | 0.02% | -47.8% |
| Q1 2021 | $488,000 | +8.9% | 11,300 | +9.5% | 0.05% | -48.9% |
| Q3 2020 | $448,000 | – | 10,324 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |